MRKR vs WAT · rev $751.7K vs P/E 32, rev $3.17B
Marker Therapeutics Inc (MRKR) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
MRKR currently screens at market cap $25.3M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the MRKR and WAT stock pages for the full models.
Not investment advice.